Bullfrog AI Holdings, Inc. (BFRG)
NASDAQ: BFRG · IEX Real-Time Price · USD
2.910
+0.050 (1.75%)
At close: Apr 26, 2024, 4:00 PM
2.950
+0.040 (1.37%)
After-hours: Apr 26, 2024, 7:14 PM EDT
Bullfrog AI Market Cap
Bullfrog AI has a market cap or net worth of $22.85 million as of April 26, 2024. Its market cap has decreased by -53.94% in one year.
Market Cap
22.85M
Enterprise Value
20.22M
1-Year Change
-53.94%
Ranking
Category
Stock Price
$2.91
Market Cap Chart
Since the IPO on February 14, 2023, Bullfrog AI's market cap has decreased from $36.86M to $22.85M, a decrease of -38.02%. That is a compound annual growth rate of -32.94%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 20.00M | 1.52% |
Apr 25, 2024 | 19.70M | -0.51% |
Apr 24, 2024 | 19.80M | -1.00% |
Apr 23, 2024 | 20.00M | 4.71% |
Apr 22, 2024 | 19.10M | 2.69% |
Apr 19, 2024 | 18.60M | -10.58% |
Apr 18, 2024 | 20.80M | 3.48% |
Apr 17, 2024 | 20.10M | - |
Apr 16, 2024 | 20.10M | -4.29% |
Apr 15, 2024 | 21.00M | -0.47% |
Apr 12, 2024 | 21.10M | -3.21% |
Apr 11, 2024 | 21.80M | -0.91% |
Apr 10, 2024 | 22.00M | -2.65% |
Apr 9, 2024 | 22.60M | 0.44% |
Apr 8, 2024 | 22.50M | -0.44% |
Apr 5, 2024 | 22.60M | -0.88% |
Apr 4, 2024 | 22.80M | 3.64% |
Apr 3, 2024 | 22.00M | 7.84% |
Apr 2, 2024 | 20.40M | -1.92% |
Apr 1, 2024 | 20.80M | -5.88% |
Mar 28, 2024 | 22.10M | -7.14% |
Mar 27, 2024 | 23.80M | -0.83% |
Mar 26, 2024 | 24.00M | 5.26% |
Mar 25, 2024 | 22.80M | -6.17% |
Mar 22, 2024 | 24.30M | -7.60% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CytoMed Therapeutics | 24.21M |
Movano | 24.13M |
Addex Therapeutics | 23.20M |
Nephros | 23.09M |
Serina Therapeutics | 22.98M |
Biora Therapeutics | 22.52M |
Context Therapeutics | 22.51M |
Lumos Pharma | 22.46M |